Skip to main content
SpringerLink
Log in

Docosahexaenoic acid and eicosapentaenoic acid reduce C-reactive protein expression and STAT3 activation in IL-6-treated HepG2 cells

  • Published:
Molecular and Cellular Biochemistry Aims and scope Submit manuscript

Abstract

C-reactive protein (CRP), an acute phase protein in humans, is predominantly produced by hepatocytes in response to interleukin-6 (IL-6). Several epidemiological studies have reported that dietary intake of n-3 polyunsaturated fatty acids (n-3 PUFAs) is inversely associated with serum CRP concentration. However, the molecular mechanism by which n-3 PUFAs reduce the serum CRP level in HepG2 cells remains unclear. The aims of this study were to examine the effect of the n-3 PUFAs, docosahexaenoic acid (DHA), and eicosapentaenoic acid (EPA), on the modulation of IL-6-induced CRP expression and to explore its possible mechanisms. We demonstrated that DHA and EPA inhibited IL-6-induced CRP protein and mRNA expression, as well as reduced CRP promoter activity in HepG2 cells. Knockdown of Signal Transducer and Activator of Transcription 3 (STAT3) and CCAAT box/Enhancer-Binding Protein β (C/EBPβ) by small interfering RNAs (siRNAs) significantly decreased IL-6-induced CRP promoter activity. Gel electrophoresis mobility shift assays (EMSA) showed that pretreatment with DHA and EPA decreased IL-6-induced STAT3 DNA binding activity but not C/EBPβ. By western blot analysis, DHA and EPA inhibited IL-6-induced STAT3 phosphorylation but not ERK1/2 or C/EBPβ. The suppression of the phosphorylation of STAT3 by DHA and EPA was further verified by immunofluorescence staining. Taken together, our results demonstrate that DHA and EPA are able to reduce IL-6-induced CRP expression in HepG2 cells via an inhibition of STAT3 activation. This mechanism, which explains the inhibitory effect of n-3 PUFAs on the CRP expression, provides new insights into the beneficial anti-inflammatory effect of n-3 PUFAs.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Mozaffarian D, Wu JHY (2011) Omega-3 fatty acids and cardiovascular disease: effects on risk factors, molecular pathways, and clinical events. J Am Coll Cardiol 58:2047–2067

    Article  CAS  PubMed  Google Scholar 

  2. De Caterina R (2011) n-3 fatty acids in cardiovascular disease. N Engl J Med 364:2439–2450

    Article  PubMed  Google Scholar 

  3. Rontoyanni VG, Sfikakis PP, Kitas GD, Protogerou AD (2012) Marine n-3 fatty acids for cardiovascular risk reduction and disease control in rheumatoid arthritis: “kill two birds with one stone”? Curr Pharm Des 18:1531–1542

    Article  CAS  PubMed  Google Scholar 

  4. Bassaganya-Riera J, Hontecillas R (2010) Dietary conjugated linoleic acid and n-3 polyunsaturated fatty acids in inflammatory bowel disease. Curr Opin Clin Nutr Metab Care 13:569–573

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Calder PC (2012) Mechanisms of action of (n-3) fatty acids. J Nutr 142:592S–5929S

    Article  CAS  PubMed  Google Scholar 

  6. Adkins Y, Kelley DS (2010) Mechanisms underlying the cardioprotective effects of omega-3 polyunsaturated fatty acids. J Nutr Biochem 21:781–792

    Article  CAS  PubMed  Google Scholar 

  7. Black S, Kushner I, Samols D (2004) C-reactive protein. J Biol Chem 279:48487–48490

    Article  CAS  PubMed  Google Scholar 

  8. Momiyama Y, Ohmori R, Fayad ZA, Kihara T, Tanaka N, Kato R, Taniguchi H, Nagata M, Nakamura H, Ohsuzu F (2010) Associations between plasma C-reactive protein levels and the severities of coronary and aortic atherosclerosis. J Atheroscler Thromb 17:460–467

    Article  CAS  PubMed  Google Scholar 

  9. Bisoendial RJ, Boekholdt SM, Vergeer M, Stroes ES, Kastelein JJ (2010) C-reactive protein is a mediator of cardiovascular disease. Eur Heart J 31:2087–2091

    Article  CAS  PubMed  Google Scholar 

  10. Buckley DI, Fu R, Freeman M, Rogers K, Helfand M (2009) C-reactive protein as a risk factor for coronary heart disease: a systematic review and meta-analyses for the U.S. Preventive Services Task Force. Ann Intern Med 151:483–495

    Article  PubMed  Google Scholar 

  11. Abd TT, Eapen DJ, Bajpai A, Goyal A, Dollar A, Sperling L (2011) The role of C-reactive protein as a risk predictor of coronary atherosclerosis: implications from the JUPITER trial. Curr Atheroscler Rep 13:154–161

    Article  CAS  PubMed  Google Scholar 

  12. Paul A, Ko KW, Li L, Yechoor V, McCrory MA, Szalai AJ, Chan L (2004) C-reactive protein accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice. Circulation 109:647–655

    Article  CAS  PubMed  Google Scholar 

  13. Pepys MB, Hirschfield GM (2003) C-reactive protein: a critical update. J Clin Invest 111:1805–1812

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Ferruci L, Cherubini A, Bandinelli S, Bartali B, Corsi A, Lauretani F, Martin A, Andres-Lacueva C, Senin U, Guralnik JM (2006) Relationship of plasma polyunsaturated fatty acids to circulating inflammatory markers. J Clin Endocrinol Metab 91:439–446

    Article  Google Scholar 

  15. Tsitouras PD, Gucciardo F, Salbe AD, Heward C, Harman SM (2008) High omega-3 fat intake improves insulin sensitivity and reduces CRP and IL6, but does not affect other endocrine axes in healthy older adults. Horm Metab Res 40:199–205

    Article  CAS  PubMed  Google Scholar 

  16. Micallef MA, Munro IA, Garg ML (2009) An inverse relationship between plasma n-3 fatty acids and C-reactive protein in healthy individuals. Eur J Clin Nutr 63:1154–1156

    Article  CAS  PubMed  Google Scholar 

  17. Farzaneh-Far R, Harris WS, Garg S, Na B, Whooley MA (2009) Inverse association of erythrocyte n-3 fatty acid levels with inflammatory biomarkers in patients with stable coronary artery disease: the Heart and Soul Study. Atherosclerosis 205:538–543

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. He K, Liu K, Daviglus ML, Jenny NS, Mayer-Davis E, Jiang R, Steffen L, Siscovick D, Tsai M, Herrington D (2009) Associations of dietary long-chain n-3 polyunsaturated fatty acids and fish with biomarkers of inflammation and endothelial activation (from the Multi-Ethnic Study of Atherosclerosis MESA). Am J Cardiol 103:1238–1243

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Kelley DS, Siegel D, Fedor DM, Adkins Y, Mackey BE (2009) DHA supplementation decreases serum C-reactive protein and other markers of inflammation in hypertriglyceridemic men. J Nutr 139:495–501

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Castell JV, Gomez-Lechion MJ, David M, Fabra R, Trullenque R, Heinrich PC (1990) Acute-phase response of human hepatocytes: regulation of acute-phase protein synthesis by interleukin-6. Hepatology 12:1179–1186

    Article  CAS  PubMed  Google Scholar 

  21. Zhang D, Sun M, Samols D, Kushner I (1996) STAT3 participates in transcriptional activation of the C-reactive protein gene by interleukin-6. J Biol Chem 271:9503–9509

    Article  CAS  PubMed  Google Scholar 

  22. Nishikawa T, Hagihara K, Serada S, Isobe T, Matsumura A, Song J, Tanaka T, Kawase I, Naka T, Yoshizaki K (2008) Transcriptional complex formation of c-Fos, STAT3, and hepatocyte NF-1 alpha is essential for cytokine-driven C-reactive protein gene expression. J Immunol 180:3492–3501

    Article  CAS  PubMed  Google Scholar 

  23. Ramji DP, Vitelli A, Tronche F, Cortese R, Ciliberto G (1993) The two C/EBP isoforms, IL-6DBP/NF-IL6 and C/EBP delta/NF-IL6 beta, are induced by IL-6 to promote acute phase gene transcription via different mechanisms. Nucleic Acids Res 21:289–294

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Li SP, Goldman ND (1996) Regulation of human C-reactive protein gene expression by two synergistic IL-6 responsive elements. Biochemistry 35:9060–9068

    Article  CAS  PubMed  Google Scholar 

  25. Patel DN, King CA, Bailey SR, Holt JW, Venkatachalam K, Agrawal A, Valente AJ, Chandrasekar B (2007) Interleukin-17 stimulates C-reactive protein expression in hepatocytes and smooth muscle cells via p38 MAPK and ERK1/2-dependent NF-κB and C/EBPβ activation. J Biol Chem 282:27229–27238

    Article  CAS  PubMed  Google Scholar 

  26. Li SP, Liu TY, Goldman ND (1990) cis-acting elements responsible for interleukin-6 inducible C-reactive protein gene expression. J Biol Chem 265:4136–4142

    CAS  PubMed  Google Scholar 

  27. Nakajima T, Kinoshita S, Sasagawa T, Sasaki K, Naruto M, Kishimoto T, Akira S (1993) Phosphorylation at threonine-235 by a ras-dependent mitogen-activated protein kinase cascade is essential for transcription factor NF-IL6. Proc Natl Acad Sci USA 90:2207–2211

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Hanlon M, Sturgill TW, Sealy L (2001) ERK2- and p90 (Rsk2)-dependent pathways regulate the CCAAT/enhancer-binding protein-beta interaction with serum response factor. J Biol Chem 276:38449–38456

    Article  CAS  PubMed  Google Scholar 

  29. Heinrich PC, Behrmann I, Haan S, Hermanns HM, Müller-Newen G, Schaper F (2003) Principles of interleukin (IL)-6-type cytokine signalling and its regulation. Biochem J 374:1–20

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Hoey T, Grusby MJ (1999) STATs as mediators of cytokine induced responses. Adv Immunol 71:145–160

    Article  CAS  PubMed  Google Scholar 

  31. Sun H, Zhang Y, Gao P, Li Q, Sun Y, Zhang J, Xu C (2011) Adiponectin reduces C-reactive protein expression and downregulates STAT3 phosphorylation induced by IL-6 in HepG2 cells. Mol Cell Biochem 347:183–189

    Article  CAS  PubMed  Google Scholar 

  32. McMurray DN, Bonilla DL, Chapkin RS (2011) n-3 Fatty acids uniquely affect anti-microbial resistance and immune cell plasma membrane organization. Chem Phys Lipids 164:626–635

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Arab K, Rossary A, Flourié F, Tourneur Y, Steghens JP (2006) Docosahexaenoic acid enhances the antioxidant response of human fibroblasts by upregulating gamma-glutamyl-cysteinyl ligase and glutathione reductase. Br J Nutr 95:18–26

    Article  CAS  PubMed  Google Scholar 

  34. Draper E, Reynolds CM, Canavan M, Mills KH, Loscher CE, Roche HM (2011) Omega-3 fatty acids attenuate dendritic cell function via NF-κB independent of PPARγ. J Nutr Biochem 22:784–790

    Article  CAS  PubMed  Google Scholar 

  35. Norris PC, Dennis EA (2012) Omega-3 fatty acids cause dramatic changes in TLR4 and purinergic eicosanoid signaling. Proc Natl Acad Sci USA 109:8517–8522

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Bannenberg G, Serhan CN (2010) Specialized pro-resolving lipid mediators in the inflammatory response: an update. Biochim Biophys Acta 1801:1260–1273

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Wang TM, Chen CJ, Lee TS, Chao HY, Wu WH, Hsieh SC, Sheu HH, Chiang AN (2011) Docosahexaenoic acid attenuates VCAM-1 expression and NF-κB activation in TNF-α-treated human aortic endothelial cells. J Nutr Biochem 22:187–194

    Article  CAS  PubMed  Google Scholar 

  38. Rahman M, Kundu JK, Shin JW, Na HK, Surh YJ (2011) Docosahexaenoic acid inhibits UVB-induced activation of NF-κB and expression of COX-2 and NOX-4 in HR-1 hairless mouse skin by blocking MSK1 signaling. PLoS ONE 6:e28065

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  39. Diaz Encarnacion MM, Warner GM, Cheng J, Gray CE, Nath KA, Grande JP (2011) n-3 Fatty acids block TNF-α-stimulated MCP-1 expression in rat mesangial cells. Am J Physiol Renal Physiol 300:F1142–F1151

    Article  PubMed  PubMed Central  Google Scholar 

  40. Wu MH, Tsai YT, Hua KT, Chang KC, Kuo ML, Lin MT (2012) Eicosapentaenoic acid and docosahexaenoic acid inhibit macrophage-induced gastric cancer cell migration by attenuating the expression of matrix metalloproteinase 10. J Nutr Biochem. doi:10.1016/j.jnutbio.2011.09.004

  41. Monk JM, Kim W, Callaway E, Turk HF, Foreman JE, Peters JM, He W, Weeks B, Alaniz RC, McMurray DN, Chapkin RS (2012) Immunomodulatory action of dietary fish oil and targeted deletion of intestinal epithelial cell PPARδ in inflammation-induced colon carcinogenesis. Am J Physiol Gastrointest Liver Physiol 302:G153–G167

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  42. Reich NC (2009) STAT3 revs up the powerhouse. Sci Signal 2:pe61

    Google Scholar 

  43. Roux PP, Blenis J (2004) ERK and p38 MAPK-activated protein kinases: a family of protein kinases with diverse biological functions. Microbiol Mol Biol Rev 68:320–344

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  44. Giachini FR, Sullivan JC, Lima VV, Carneiro FS, Fortes ZB, Pollock DM, Carvalho MH, Webb RC, Tostes RC (2010) Extracellular signal-regulated kinase 1/2 activation, via downregulation of mitogen-activated protein kinase phosphatase 1, mediates sex differences in desoxycorticosterone acetate-salt hypertension vascular reactivity. Hypertension 55:172–179

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  45. Kaur G, Rao LV, Agrawal A, Pendurthi UR (2007) Effect of wine phenolics on cytokine-induced C-reactive protein expression. J Thromb Haemost 5:1309–1317

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgments

This study was supported by grants from the VGHUST Joint Research Program Tsou’s Foundation and Aim for the Top University Plan, Ministry of Education (101AC-P504), Taiwan, ROC.

Author information

Authors and Affiliations

  1. Institute of Biochemistry and Molecular Biology, National Yang-Ming University, Taipei, 112, Taiwan

    Tzu-Ming Wang & An-Na Chiang

  2. Institute of Food Science and Technology, National Taiwan University, Taipei, 112, Taiwan

    Shu-Chen Hsieh

  3. Division of Cardiology, Department of Medicine, Taipei Veterans General Hospital, and Institute of Pharmacology, National Yang-Ming University, Taipei, 112, Taiwan

    Jaw-Wen Chen

Authors
  1. Tzu-Ming Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Shu-Chen Hsieh
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jaw-Wen Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. An-Na Chiang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to An-Na Chiang.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wang, TM., Hsieh, SC., Chen, JW. et al. Docosahexaenoic acid and eicosapentaenoic acid reduce C-reactive protein expression and STAT3 activation in IL-6-treated HepG2 cells. Mol Cell Biochem 377, 97–106 (2013). https://doi.org/10.1007/s11010-013-1574-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11010-013-1574-1

Keywords

Search

Navigation